• Users Online: 402
  • Print this page
  • Email this page

    Article Cited by others

DRUG PROFILE

Topical rapamycin (sirolimus) for facial angiofibromas

Madke Bhushan

Year : 2013| Volume: 4| Issue : 1 | Page no: 54-57

   This article has been cited by
 
1 Prospective pilot study on combined use of pulsed dye laser and 1% topical rapamycin for treatment of nonfacial cutaneous capillary malformation
Eun Jin Doh,Jungyoon Ohn,Min Ji Kim,Young Gull Kim,Soyun Cho
Journal of Dermatological Treatment. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy
Na Liu,Liuqing Xu,Yingfeng Shi,Shougang Zhuang
Journal of Diabetes Research. 2017; 2017: 1
[Pubmed]  [Google Scholar] [DOI]
3 Nonsteroidal Topical Immunomodulators in Allergology and Dermatology
Marina Jovanovic,Zoran Golušin
BioMed Research International. 2016; 2016: 1
[Pubmed]  [Google Scholar] [DOI]
4 Formulation and characterization of a 0.1% rapamycin cream for the treatment of Tuberous Sclerosis Complex-related angiofibromas
Guillaume Bouguéon,Frédéric Lagarce,Ludovic Martin,Hélčne Pailhoričs,Guillaume Bastiat,Sandy Vrignaud
International Journal of Pharmaceutics. 2016; 509(1-2): 279
[Pubmed]  [Google Scholar] [DOI]
5 Treatment of port wine stains using Pulsed Dye Laser, Erbium YAG Laser, and topical rapamycin (sirolimus)-A randomized controlled trial
Karin Greveling,Errol P. Prens,Martijn B. van Doorn
Lasers in Surgery and Medicine. 2016;
[Pubmed]  [Google Scholar] [DOI]
6 Phosphoinositide 3-kinase: a new kid on the block in vascular anomalies
Sandra D Castillo,Bart Vanhaesebroeck,Neil J Sebire
The Journal of Pathology. 2016;
[Pubmed]  [Google Scholar] [DOI]
7 Levels of sirolimus in saliva and blood following oral topical sustained-release varnish delivery system application
Zakhar Nudelman,Mordechai Findler,Dinorah Barasch,Alina Nemirovski,Anna Pikovsky,David Kirmayer,Maamoun Basheer,J. Silvio Gutkind,Michael Friedman,Rakefet Czerninski
Cancer Chemotherapy and Pharmacology. 2015;
[Pubmed]  [Google Scholar] [DOI]
8 Sirolimus formulation with improved pharmacokinetic properties produced by a continuous flow method
Tamás Solymosi,Réka Angi,Orsolya Basa-Dénes,Soma Ránky,Zsolt Ötvös,Hristos Glavinas,Genovéva Filipcsei,Gábor Heltovics
European Journal of Pharmaceutics and Biopharmaceutics. 2015; 94: 135
[Pubmed]  [Google Scholar] [DOI]
9 Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: Follow up of a pilot study and promising future directions
Jenny Tu,Rachael S Foster,Lewis J Bint,Anne R Halbert
Australasian Journal of Dermatology. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
10 Levels of sirolimus in saliva and blood following mouthwash application
Z Nudelman,M Friedman,D Barasch,A Nemirovski,M Findler,A Pikovsky,JS Gutkind,R Czerninski
Oral Diseases. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
11 Nd:YAG laser for “fractional” treatment of angiofibromas
Gang Ma,Pinru Wu,Xiaoxi Lin,Hui Chen,Wei Li,Xiaojie Hu,Yunbo Jin
International Journal of Dermatology. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
12 Research Spotlight: Sirolimus-coated stents for airway tracheal stenosis: a future 3D model concept with today’s knowledge
Paul Zarogoulidis,Kaid Darwiche,Robert Walter,Qiang Li,Helmut Teschler,Lutz Freitag,Konstantinos Zarogoulidis
Therapeutic Delivery. 2013; 4(9): 1093
[Pubmed]  [Google Scholar] [DOI]

 

Read this article